Forbes Ranks Epic’s Judith Faulkner the Richest Woman in Healthcare in Its 2021 List of 100 Richest Self-Made Women in US

Within the in vitro diagnostics and clinical laboratory space, Bio-Rad’s Alice Schwartz and 23andMe’s Anne Wojcicki also were recognized by Forbes At $6.5 billion net worth, Forbes, in its 2021 list of the 100 richest self-made women in the US, ranked Judith Faulkner, Chief Executive Officer and founder of Epic Systems Corp., in second place overall. But in the industry of healthcare, she tops the list by far. The next nearest healthcare-related “richest woman” is Alice Schwartz, co-founder of...

GE Healthcare Pays $587 Million to Purchase Clarient, the Specialty Pathology and Cancer Testing Firm

GE’s Acquisition Considered A Sign Of More Deals To Come In The Clinical Laboratory Industry Here’s more confirmation that anatomic pathology continues to be a big target on the radar screen of big healthcare corporations and Wall Street investors. Today, GE Healthcare, a unit of General Electric Company (NYSE: GE), disclosed it will pay $587 million to acquire Clarient, Inc. (NASDAQ: CLRT), the medical testing laboratory. For pathologists and clinical laboratory managers, this is...

Thermo Fisher Offers $6 Billion to Acquire Millipore

Both companies are important suppliers to clinical laboratories and research labs In recent days, news surfaced that Thermo Fisher Scientific Inc. (NYSE: TMO) was offering $6 billion to acquire Millipore Corporation (NYSE:MIL). Neither company has confirmed the offer, but yesterday Millipore issued a statement that its Directors were “evaluating strategic options.” Should Thermo Fisher acquire Millipore, or should Millipore find another buyer, it will mean the same thing: more...

Pathologists Soon to say Sayonara to Glass Slides!

Digital Pathology Imaging: Coming Soon to a Pathology Group near You! Will pathologists soon say “sayonara” to glass slides? Plenty of smart money already bets the answer to that question is “yes”! Every pathologist in the United States and abroad should be watching developments in whole slide imaging and digital pathology systems. That’s because digital pathology imaging is a trend with momentum-and it also has the potential to be disruptive, although probably...

General Electric and Abbott Laboratories Cancel Their $8.13 Billion Deal

After the markets closed yesterday, General Electric (NYSE: GE) and Abbott Laboratories (NYSE: ABT) released announcements that the two companies had terminated the pending sale of Abbott’s two diagnostic business units to General Electric. Abbott’s press release made the announcement in two sentences: “Abbott and GE have mutually agreed to terminate their contract for the sale of Abbott’s core laboratory and point-of-care diagnostics businesses to GE. The two companies were unable to agree on...
;